Tarsus Pharmaceuticals Inc.
TARS | NASDAQ
$77.46
-$0.63 (-0.81%)
At close: Sep 21, 2026, 4:00 PM ET
$77.46
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Market Data
Market Cap $3.36B
Enterprise Value $2.88B
Beta 0.54
Average Volume 914.09K
Shares Outstanding (Diluted) 43.39M
Shares Change YoY 2.44%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US87650L1035
Price Performance
Price Change 1M 6.1%
Price Change 3M 17.1%
Price Change 6M 15.7%
Price Change YTD -4.1%
Price Change 1Y 39.2%
Price Change 3Y 357.0%
Price Change 5Y 240.0%
1M CAGR (ann.) 19.5%
1Y CAGR (ann.) 51.1%
5Y CAGR (ann.) 28.5%
All-Time CAGR 25.2%
Valuation
PE Ratio -71.06
Forward PE 28.07
PEG Ratio -0.86
Forward PEG 0.41
PS Ratio 5.50
Forward PS 3.70
PB Ratio 9.61
P/FCF Ratio 54.15
P/Adj. FCF Ratio 342.37
P/OCF Ratio 42.10
EV/Sales 4.75
EV/EBIT -76.77
EV/EBITDA -81.87
EV/FCF 46.84
Earnings Yield -1.4%
FCF Yield 1.9%
Adj. FCF Yield 0.3%
Financial Health
Net Cash $449.69M
Total Debt $0
Cash & Short-Term Investments $449.69M
Total Assets $611.14M
Current Ratio 3.20
Quick Ratio 3.17
Debt / Equity Ratio 0.26
Debt / EBITDA -0.00
Debt / FCF 0.00
OCF / Debt N/A
Interest Coverage -5.63
Altman Z-Score 8.14
Piotroski F-Score 5
Margins & Profitability
Gross Profit Margin 90.6%
Operating Profit Margin -8.0%
EBITDA Margin -5.8%
Net Profit Margin -7.7%
FCF Margin 10.2%
Adj. FCF Margin 1.6%
SBC / Revenue 8.6%
SBC Impact (per share) -84.2%
Returns
Return on Assets -7.6%
Return on Equity -13.5%
Return on Invested Capital -11.2%
Return on Capital Employed -11.2%
Return on Tangible Assets -7.7%
Historical Growth (CAGR)
Revenue CAGR 3Y 264.7%
Revenue CAGR 5Y 61.4%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 64.4%
EPS CAGR 5Y 15.4%
EPS CAGR 10Y N/A
FCF CAGR 3Y 184.0%
FCF CAGR 5Y 31.5%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 10
EPS Growth Next 3Y 226.6%
Revenue Growth Next 3Y 27.9%
Earnings Date Nov 2, 2026
EPS Estimate (next Q) -$1.43
EPS Growth Est (next Q) 376.7%
Revenue Est (next Q) $183.75M
Revenue Growth Est (next Q) 54.8%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $100.40
Price Target Upside 29.6%
Cash Flow
Operating Cash Flow $79.7M
Free Cash Flow $61.55M
Adj. Free Cash Flow $9.73M
FCF Per Share $1.42
OCF Per Share $1.84
OCF/S Ratio 13.1%
Income Statement
Revenue $606.33M
Gross Profit $549.3M
Operating Income $-48.54M
EBITDA $-35.22M
Net Income $-46.48M
EPS (Diluted) -$1.09
Revenue / Employee $1.64M
Profit / Employee $-125.61K
Employees 370
Add to Watchlist
Select watchlists to add or remove TARS